Dr. Alan Frey obtained a bachelor’s degree in Chemistry and Biology from Grinnell College (1977). He then obtained a PhD in Cell Biology from the Sackler Institute of Biomedical Sciences at New York University (1985) before completing postdoctoral training in Molecular Biology at Princeton University (1988). Dr. Frey has spent over three decades dedicating his research to pursuit of the mechanistic basis underlying tumor-induced blockade of effector T cell function. Most recently, he has served as a consultant for numerous pharmaceutical and biotech companies.

As a member of the Advisory Board for Radyus, Dr. Frey brings with him over 30 years of experience investigating the mechanistic basis of disease. He also has extensive consulting experience working with pharmaceutical and biotech companies. Dr. Frey worked as Professor of Cell Biology at the New York University Grossman School of Medicine for over 30 years (1988-2020). He has worked as a consultant for pharmaceutical and biotech companies as well: RxTechnologies (1990-1996), BeneVir Biopharm (2013-2018), and Cytodel Corp (2014-2020). Currently, he serves as a consultant and Chief Scientific Officer at Cambium Oncology.

Dr. Frey’s research experience as Professor of Cell Biology and more recent work as Chief Scientific Officer at Cambium oncology are invaluable to our work at Radyus. Frey has published over 90 peer-reviewed articles. His research has led to several significant scientific contributions over the years, including discovery of topography of cytochrome P450 enzymes, identification of existence of tumor rejection antigens, T cell immune responses in cancer, discover of a novel interacting partner for T cell Src kinase (p56), discovery of novel CD8+ T cell immune destruction of pancreatic islet cells. His independent lab has used predictive algorithms to try to create a drug to eliminate T cells that kill pancreatic beta cells in order to reestablish normoglycemia.

Dr. Alan Frey has a bachelor’s degree in Chemistry and Biology from Grinnell College and a PhD in Cell Biology from the Sackler Institute of Biomedical Sciences at New York University. Dr. Frey has received numerous honors and distinctions throughout his career, some of which include the Dean’s Recognition Citation for Excellence in Medical Education from NYUSM, the Irma T. Hirschl-Monique Weill Caulier Career Development Award, the Whitehead Presidential Fellowship, the PHS NRS Fellowship (twice), the Anna Fuller Fund Fellowship, the Rose M. Badgely Scholarship, and the International Scientist Exchange Award from Hoffman-LaRoche. He has been on several grant review panels and has numerous professional memberships. In addition, Frey has extensive teaching and mentoring experience, having been a committee member for over three dozen doctoral students at six different institutions, mentored over two dozen undergraduate research and honors program students at NYU, and served on various university committees and as a member for five NIH training programs.